Pauline Dürr

11PUBLICATIONS
27CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesToxicology (incl. clinical toxicology)Gene and molecular therapyNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 22, 2025
Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World Data.

Michael I Sponfeldner, Pauline Dürr, Phyllis Lensker

|Jul 18, 2025
Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics.

Lisa Cuba, Frank Dörje, Rafaela Kramer

|Nov 08, 2024
Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics".

Wahram Andrikyan, Michael I Sponfeldner, Lea Jung-Poppe

|Jun 07, 2024
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center.

Lisa Cuba, Pauline Dürr, Katja Gessner

|Apr 24, 2024
From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy.

Lisa Cuba, Pauline Dürr, Frank Dörje

|Jun 10, 2023
Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center.

Lisa Cuba, Katja Schlichtig, Pauline Dürr

Pageof 2

Frequent Collaborators

10 joint publications

Martin F Fromm

5 joint publications

Frank Dörje

5 joint publications

Lisa Cuba

4 joint publications

Renke Maas